Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Legend Biotech Corp (LEGN US)
Watchlist
97
Analysis
Health Care
•
China
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Genscript Biotech
•
09 Jun 2024 16:00
China Healthcare Weekly (Jun.9) - New Akeso-Summit Deal, Jacobio Is a Good Bet, Genscript's Trouble
The new Akeso-Summit deal may pave the way for MNC to acquire Summit.Jacobio is a good target for potential M&A/license deal.Genscript faces US...
Xinyao (Criss) Wang
Follow
602 Views
Share
bullish
•
Legend Biotech Corp
•
25 May 2024 14:00
Legend Biotech Corporation: Implementation of Commercial Launch of CARVYKTI & Other Major Drivers
Legend Biotech Corporation is a biotech company specializing in CAR-T cell therapy for the treatment of multiple myeloma. In Quarter 1 2024, two...
Baptista Research
Follow
759 Views
Share
bullish
•
Legend Biotech Corp
•
03 Apr 2024 08:55
Legend Biotech Corp (LEGN.US) - FDA's Upcoming Decision on Carvykti Will Change the Whole Landscape
If Carvykti's approved for 2L therapy, it will be a game changer in MM treatment. But Legend Bio's market value performance may be inferior to...
Xinyao (Criss) Wang
Follow
558 Views
Share
bullish
•
Legend Biotech Corp
•
26 Mar 2024 15:00
Legend Biotech Corporation: Initiation of Coverage - Can They Flourish In The Competitive CAR-T Therapy Market? - Major Drivers
This is our first report on biopharma player, Legend Biotech. The company's Q4 earnings call displayed a balance of positive and negative...
Baptista Research
Follow
246 Views
Share
bullish
•
BeiGene
•
19 Feb 2024 08:55
BeiGene (6160.HK/BGNE.US/688235.CH) - 2023 Results Preview and Undervaluation Concerns
BeiGene's sluggish share price could be related to geopolitical conflicts/weak market sentiment. But there’s no need for US to sanction China's...
Xinyao (Criss) Wang
Follow
431 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x